Impact of Preanalytical Variations in Blood-Derived Biospecimens on Omics Studies: Toward Precision Biobanking?

Abstract Research data and outcomes do vary across populations and persons, but this is not always due to experimental or true biological variation. Preanalytical components of experiments, be they biospecimen acquisition, preparation, storage, or transportation to the laboratory, may all contribute to apparent variability in research data, outcomes, and interpretation. The present review article and biobanking innovation analysis offer new insights with a summary of such preanalytical variables, for example, the type of blood collection tube, centrifugation conditions, long-term sample storage temperature, and duration, on output of omics analyses of blood-derived biospecimens: whole blood, serum, plasma, buffy coat, and peripheral blood mononuclear cells. Furthermore, we draw parallels from the field of precision medicine in this study, with a view to the future of “precision biobanking” wherein such preanalytical variations are carefully taken into consideration so as to minimize their influence on out...

[1]  N. Thelwell,et al.  The quality of DNA extracted from liquid or dried blood is not adversely affected by storage at 4 degrees C for up to 24 h. , 2008, International journal of epidemiology.

[2]  Irena Spasic,et al.  A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. , 2008, International journal of epidemiology.

[3]  Marie-Christine W. Gast,et al.  Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS) , 2009, Clinical chemistry and laboratory medicine.

[4]  Sabine C. Mueller,et al.  Influence of next-generation sequencing and storage conditions on miRNA patterns generated from PAXgene blood. , 2015, Analytical chemistry.

[5]  Robin Williams,et al.  Compressed Foresight and Narrative Bias: Pitfalls in Assessing High Technology Futures , 2006 .

[6]  H. Katus,et al.  Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling. , 2017, Clinical biochemistry.

[7]  Stefan Enroth,et al.  Stability of Proteins in Dried Blood Spot Biobanks , 2017, Molecular & Cellular Proteomics.

[8]  B. Han,et al.  Impact of Whole-Blood Processing Conditions on Plasma and Serum Concentrations of Cytokines. , 2016, Biopreservation and biobanking.

[9]  Francesco M Marincola,et al.  Effects of storage time and exogenous protease inhibitors on plasma protein levels. , 2006, American journal of clinical pathology.

[10]  G. Karypis,et al.  Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation , 2004, Genes and Immunity.

[11]  M. Feisal,et al.  Toward a Reference Gene Catalog of Human Primary Monocytes. , 2016 .

[12]  P. Elliott,et al.  High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. , 2008, International journal of epidemiology.

[13]  Sen-Yung Hsieh,et al.  Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling , 2006, Proteomics.

[14]  B. Han,et al.  Inorganic Phosphorus and Potassium Are Putative Indicators of Delayed Separation of Whole Blood , 2015, Osong public health and research perspectives.

[15]  J. López,et al.  ELSIfication in Canada: Legal Modes of Reasoning , 2012 .

[16]  T. Williams,et al.  A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. , 2013, Clinical biochemistry.

[17]  M. Hellmich,et al.  Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types , 2004, The Pharmacogenomics Journal.

[18]  A. Dirican,et al.  The effect of storage time and freeze-thaw cycles on the stability of serum samples , 2013, Biochemia medica.

[19]  A. Petersen.  From bioethics to a sociology of bio-knowledge. , 2013, Social science & medicine.

[20]  Niroshini Nirmalan,et al.  “Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives , 2016, Proteomes.

[21]  Maddie Smith,et al.  Quantitative analysis of genomic DNA degradation in whole blood under various storage conditions for molecular diagnostic testing. , 2015, Molecular and cellular probes.

[22]  K. Matsuda,et al.  Adjustment of Cell-Type Composition Minimizes Systematic Bias in Blood DNA Methylation Profiles Derived by DNA Collection Protocols , 2016, PloS one.

[23]  Rachel Ostroff,et al.  The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. , 2010, Journal of proteomics.

[24]  Tamás Korcsmáros,et al.  Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex , 2017, Genom. Proteom. Bioinform..

[25]  D. Morrow,et al.  Preanalytical considerations in the design of clinical trials and epidemiological studies. , 2015, Clinical chemistry.

[26]  M. Pescatori,et al.  miRNA Stability in Frozen Plasma Samples , 2015, Molecules.

[27]  Nathalie Zahra,et al.  Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids , 2013, PloS one.

[28]  Paolo Vineis,et al.  Performance in Omics Analyses of Blood Samples in Long-Term Storage: Opportunities for the Exploitation of Existing Biobanks in Environmental Health Research , 2013, Environmental health perspectives.

[29]  J. Livesey,et al.  Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. , 2001, Clinical biochemistry.

[30]  Gabi Kastenmüller,et al.  Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples , 2015, PloS one.

[31]  V. Seyfert-Margolis,et al.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.

[32]  K. Jung,et al.  Changes in concentration of DNA in serum and plasma during storage of blood samples. , 2003, Clinical chemistry.

[33]  D. Bowden,et al.  Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long term storage , 2011, Journal of Translational Medicine.

[34]  M. Plebani,et al.  Quality indicators to detect pre-analytical errors in laboratory testing. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[35]  K. C. Chan,et al.  Effects of preanalytical factors on the molecular size of cell-free DNA in blood. , 2005, Clinical chemistry.

[36]  Peter Kraft,et al.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. , 2013, Clinical chemistry.

[37]  Umberto Nanni,et al.  Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). , 2012, Biopreservation and biobanking.

[38]  M. Ranson,et al.  Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer , 2008, Annals of the New York Academy of Sciences.

[39]  Alicia Algeciras-Schimnich,et al.  Analysis of circulating microRNA: preanalytical and analytical challenges. , 2011, Clinical chemistry.

[40]  Joana Pinto,et al.  Human plasma stability during handling and storage: impact on NMR metabolomics. , 2014, The Analyst.

[41]  F. Mouliere,et al.  Circulating cell free DNA: Preanalytical considerations. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[42]  William E Grizzle,et al.  Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. , 2009, Journal of proteome research.

[43]  Simone Wahl,et al.  Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples , 2014, PloS one.

[44]  R. Chiu,et al.  EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. , 2004, Clinical chemistry.

[45]  M. I. Mora,et al.  Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods. , 2017, Journal of proteomics.

[46]  Hee Sung Kim,et al.  Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group , 2016, Biopreservation and biobanking.

[47]  E. Dove,et al.  Biobanks in Oral Health: Promises and Implications of Post-Neoliberal Science and Innovation. , 2016, Omics : a journal of integrative biology.

[48]  Michael G. Barnes,et al.  Gene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing Delays. , 2010, Biopreservation and biobanking.

[49]  Alptekin Aksan,et al.  State of the art in preservation of fluid biospecimens. , 2011, Biopreservation and biobanking.

[50]  I. Holen,et al.  Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[51]  Pierre Lescuyer,et al.  LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic acid levels , 2016, Metabolomics.

[52]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[53]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[54]  E. Susser,et al.  Long-term storage of blood RNA collected in RNA stabilizing Tempus tubes in a large biobank – evaluation of RNA quality and stability , 2014, BMC Research Notes.

[55]  R. Fischer,et al.  Plasma degradome affected by variable storage of human blood , 2016, Clinical Proteomics.

[56]  A. Barrett,et al.  Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield , 2011, PloS one.

[57]  H. Portugal,et al.  Stability study of 81 analytes in human whole blood, in serum and in plasma. , 2012, Clinical biochemistry.

[58]  L. Mariani,et al.  Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. , 2005, Journal of the National Cancer Institute.

[59]  A. Fitzpatrick,et al.  Impact of Freeze-thaw Cycles and Storage Time on Plasma Samples Used in Mass Spectrometry Based Biomarker Discovery Projects , 2005, Cancer informatics.

[60]  D. Hougaard,et al.  Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. , 2008, Journal of immunological methods.

[61]  N. Hacker,et al.  Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma , 2014, BMC Genomics.

[62]  Zhiyuan Luo,et al.  Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. , 2007, Clinical chemistry.

[63]  Guang-hong Guo,et al.  Clinical evaluation of the levels of 12 cytokines in serum/plasma under various storage conditions using evidence biochip arrays. , 2013, Molecular medicine reports.